Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 04 Aug 2026 for Ultragenyx Pharmaceutical Inc., €41k. Read the official filing
Filing timeline
BuySaleKarah Herdman Parschauer
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Karah Herdman Parschauer: trading record in brief
Filings by Karah Herdman Parschauer span 2 companies, the busiest being Ultragenyx Pharmaceutical Inc. and Evolus, Inc. Over a trading history stretching from 6 May 2021 to 3 August 2026, the count stands at 24 filings.
The open-market record consists of 13 sales worth €1.8M, with no purchase. Besides market trades, the filings include 10 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 2 sales.
The latest filing, published on 4 August 2026, reports an open-market sale of €41k in Ultragenyx Pharmaceutical Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Karah Herdman Parschauer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
1,900 shares@ US$24.92Common StockSEC:0001193125-26-332547:0
28,895 shares0Common StockSEC:0001193125-26-164281:0
6,018 shares@ US$21.406.1% of flowCommon StockSEC:0001193125-26-100309:0
11,137 shares0Common StockSEC:0001193125-26-089111:0
45,559 shares0Common StockSEC:0001570562-26-000027:0
2,450 shares@ US$31.173.8% of flowCommon StockSEC:0001677455-25-000005:0
12,888 shares@ US$12.993951.5% of flowCommon StockSEC:0001570562-25-000046:0
7,364 shares0Common StockSEC:0001570562-25-000035:0
18,443 shares0Common StockSEC:0000950170-25-032798:0
2,230 shares@ US$42.934.3% of flowCommon StockSEC:0000950170-25-030639:0
9,806 shares@ US$45.0019.0% of flowCommon StockSEC:0000950170-24-072621:0
17,800 shares0Common StockSEC:0000950170-24-026666:0
6,464 shares0Common StockSEC:0001570562-24-000021:0
11,931 shares@ US$13.136648.5% of flowCommon StockSEC:0001570562-24-000005:0
4,378 shares@ US$45.008.3% of flowCommon StockSEC:0001209191-23-027601:0
2,663 shares0Common StockSEC:0001209191-23-016047:0
8,293 shares0Common StockSEC:0001570562-23-000023:0
5,140 shares@ US$62.950.012% mcap20.3% of flowCommon StockSEC:0001209191-22-016931:0
2,886 shares@ US$66.620.0070% mcap11.7% of flowCommon StockSEC:0001209191-22-015811:0
15,568 shares0Common StockSEC:0001570562-22-000050:0
310 shares@ US$81.141.2% of flowCommon StockSEC:0001209191-21-060752:0
7,336 shares@ US$54.5018.6% of flowCommon StockSEC:0001209191-21-055362:0
1,329 shares@ US$100.006.0% of flowCommon StockSEC:0001209191-21-040108:0
313 shares@ US$113.671.6% of flowCommon StockSEC:0001209191-21-031388:0
24 of 24 declarations
